학술논문
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
Document Type
Article
Author
Farge, Dominique ; Loisel, Séverine; Resche-Rigon, Matthieu; Lansiaux, Pauline; Colmegna, Ines; Langlais, David; Charles, Catney; Pugnet, Grégory; Maria, Alexandre Thibault Jacques; Chatelus, Emmanuel; Martin, Thierry; Hachulla, Eric; Kheav, Vissal David; Lambert, Nathalie C; Wang, HanChen; Michonneau, David; Martinaud, Christophe; Sensebé, Luc ; Cras, Audrey; Tarte, Karin
Source
In The Lancet Rheumatology February 2022 4(2):e91-e104
Subject
Language
ISSN
2665-9913